DSpace ISS DSpace ISS DSpace ISS
 

DSpace ISS >

Browsing by Author Gobbi PG

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:   
Sort by: In order: Results/Page Authors/Record:
Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)
2005ABVD Versus Modified Stanford V Versus MOPPEBVCAD With Optional and Limited Radiotherapy in Intermediate- and Advanced-Stage Hodgkin's Lymphoma: Final Results of a Multicenter Randomized Trial by the Intergruppo Italiano LinfomiGobbi PG; Levis A; Chisesi T; Broglia C; Vitolo U; Stelitano C; Pavone V; Cavanna L; Santini G; Merli F; Liberati M; Baldini L; Deliliers GL; Angelucci E; Bordonaro R; Federico M
2007Bortezomib-induced paralytic ileus is a potential gastrointestinal side effect of this first-in- class anticancer proteasome inhibitorPerfetti V; Palladini G; Brunetti L; Sgarella A; Brugnatelli S; Gobbi PG; Corazza GR
2004The clinical value of tumor burden at diagnosis in Hodgkin lymphomaGobbi PG; Broglia C; Di Giulio G; Mantelli M; Anselmo P; Merli F; Zinzani PL; Rossi G; Callea V; Iannitto E; Paulli M; Garioni L; Ascari E
2006The length of treatment of aggressive non-Hodgkin's lymphomas established according to the international prognostic index score: long-term results of the GISL LA03 studyFederico M; Luminari S; Gobbi PG; Sacchi S; Renzo N; Lombardo M; Merli F; Baldini L; Stelitano C; Partesotti G; Polimeno G; Montanini A; Mammi C; Brugiatelli M
2006MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumorsGobbi PG; Broglia C; Levis A; La Sala A; Valentino F; Chisesi T; Sacchi S; Corbella F; Cavanna L; Iannitto E; Pavone V; Molica S; Corazza GR; Federico M
2007Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens A GISL studyFederico M; Guglielmi C; Luminari S; Mammi C; Marcheselli L; Gianelli U; Maiorana A; Merli F; Bellei M; Pozzi S; Stelitano C; Lazzaro A; Gobbi PG; Baldini L; Bergantini S; Fregoni V; Brugiatelli M
2005Prognostic validation of the international classification of immunoglobulin M gammopathies: A survival advantage for patients with immunoglobulin m monoclonal gammopathy of undetermined significance?Gobbi PG; Baldini L; Broglia C; Goldaniga M; Comelli M; Morel P; Morra E; Cortelazzo S; Bettini R; Merlini G
2006The role of dose size in a chemotherapy regimen (ProMECE-CytaBOM) for the first-line treatment of large B-cell lymphomas: a randomized trial by the Gruppo Italiano Studio Linfomi (GISL)Gobbi PG; Broglia C; Valentino F; Mammi C; Lombardo M; Merli F; Luminari S; Polimeno G; Riezzo A; Lambelet P; Rovati A; Corazza GR; Federico M
Showing results 1 to 8 of 8

 

Valid XHTML 1.0! DSpace ISS  Istituto Superiore di Sanità  - Feedback